The EANM and SNMMI practice guideline for lymphoscintigraphy and sentinel node localization in breast cancer

PurposeThe accurate harvesting of a sentinel node in breast cancer includes a sequence of procedures with components from different medical specialities, including nuclear medicine, radiology, surgical oncology and pathology. The aim of this document is to provide general information about sentinel lymph node detection in breast cancer patients.MethodsThe Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the European Association of Nuclear Medicine (EANM) have written and approved these guidelines to promote the use of nuclear medicine procedures with high quality. The final result has been discussed by distinguished experts from the EANM Oncology Committee, the SNMMI and the European Society of Surgical Oncology (ESSO).ConclusionThe present guidelines for nuclear medicine practitioners offer assistance in optimizing the diagnostic information from the SLN procedure. These guidelines describe protocols currently used routinely, but do not include all existing procedures. They should therefore not be taken as exclusive of other nuclear medicine modalities that can be used to obtain comparable results. It is important to remember that the resources and facilities available for patient care may vary.

[1]  P. Bourgeois.  Scintigraphic Investigations of the Lymphatic System: The Influence of Injected Volume and Quantity of Labeled Colloidal Tracer , 2007, Journal of Nuclear Medicine.

[2]  F. Guillemin,et al.  Results of Preoperative Lymphoscintigraphy for Breast Cancer Are Predictive of Identification of Axillary Sentinel Lymph Nodes , 2005, World Journal of Surgery.

[3]  S. Natsugoe,et al.  Carcinomatous Lymphatic Invasion in Early Gastric Cancer Invading Into the Submucosa , 1999, Annals of Surgical Oncology.

[4]  M. Ernst,et al.  304 Meta-analysis of predictive factors for non sentinel lymph node metastases in breast cancer patients with a positive SLN , 2010 .

[5]  Lenka Vermeeren,et al.  Optimizing the colloid particle concentration for improved preoperative and intraoperative image-guided detection of sentinel nodes in prostate cancer , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[6]  Breast conservation and sentinel lymph node biopsy after neoadjuvant systemic therapy. , 2009, Breast.

[7]  F W van der Ent,et al.  Sentinel node biopsy in 70 unselected patients with breast cancer: increased feasibility by using 10 mCi radiocolloid in combination with a blue dye tracer. , 1999, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[8]  A. Stojadinovic,et al.  Standard versus pH-adjusted and lidocaine supplemented radiocolloid for patients undergoing sentinel-lymph-node mapping and biopsy for early breast cancer (PASSION-P trial): a double-blind, randomised controlled trial. , 2009, The Lancet. Oncology.

[9]  D. Swanson,et al.  Procedure Guideline for the Use of Radiopharmaceuticals 4.0* , 2007, Journal of Nuclear Medicine Technology.

[10]  G. Viale,et al.  Sentinel Node Biopsy Is Not a Standard Procedure in Ductal Carcinoma In Situ of the Breast: The Experience of the European Institute of Oncology on 854 Patients in 10 Years , 2008, Annals of surgery.

[11]  Peter J. Ell,et al.  The Sentinel Node in Surgical Oncology , 1999 .

[12]  J. Rusby,et al.  Sentinel lymph node biopsy after previous axillary surgery: A review. , 2012, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[13]  P. Ell,et al.  Sentinel lymph node detection and imaging , 1999, European Journal of Nuclear Medicine.

[14]  A. Alavi,et al.  Current status of sentinel lymph-node biopsy in patients with breast cancer , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[15]  A. Luini,et al.  Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[16]  M. Wrzesień,et al.  Sentinel node biopsy in patients with breast cancer--evaluation of exposure to radiation of medical staff. , 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[17]  M. Specht,et al.  Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy? , 2005, Journal of the American College of Surgeons.

[18]  Processing sentinel nodes in breast cancer: when and how many? , 2011, Archives of surgery.

[19]  K. Knešaurek,et al.  Effective dose in sentinel lymph node imaging. , 2004, British Journal of Radiology.

[20]  E. Rutgers,et al.  Should the Hunt for Internal Mammary Chain Sentinel Nodes Begin? An Evaluation of 150 Breast Cancer Patients , 2003, Annals of Surgical Oncology.

[21]  Umberto Veronesi,et al.  A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. , 2003, The New England journal of medicine.

[22]  S. Strand,et al.  Autocorrelation spectroscopy for particle sizing and stability tests of radiolabelled colloids , 2004, European Journal of Nuclear Medicine.

[23]  K. McMasters,et al.  Preoperative lymphoscintigraphy for breast cancer does not improve the ability to identify axillary sentinel lymph nodes. , 2000, Annals of surgery.

[24]  H. Cody,et al.  Is the “10% Rule” Equally Valid for All Subsets of Sentinel-Node-Positive Breast Cancer Patients? , 2008, Annals of Surgical Oncology.

[25]  P. Flicek,et al.  Guidelines for the Safe Use of Radioactive Materials During Localization and Resection of the Sentinel Lymph Node , 1999, Annals of Surgical Oncology.

[26]  C. Compton,et al.  The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM , 2010, Annals of Surgical Oncology.

[27]  E. Rutgers,et al.  Role of axillary clearance after a tumor-positive sentinel node in the administration of adjuvant therapy in early breast cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  P. V. van Diest,et al.  Micrometastases or isolated tumor cells and the outcome of breast cancer. , 2009, The New England journal of medicine.

[29]  A. Giuliano,et al.  Radioguided surgery : a comprehensive team approach , 2008 .

[30]  R. Gelber,et al.  Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009 , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[31]  V. Bardou,et al.  Nonvisualization of axillary sentinel node during lymphoscintigraphy: is there a pathologic significance in breast cancer? , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[32]  V. Gebski,et al.  Internal mammary node metastasis in breast cancer: predictive models to determine status & management algorithms. , 2010, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[33]  R. Newcombe,et al.  Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer – results of the ALMANAC validation phase , 2006, Breast Cancer Research and Treatment.

[34]  R. Rouzier,et al.  Safety of sentinel node biopsy in pregnant patients. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[35]  J. Vicente,et al.  Optimización de la biopsia selectiva de ganglio centinela en el cáncer de mama mediante palpación axilar intraoperatoria , 2010 .

[36]  J. Benson,et al.  Management of the axilla in women with breast cancer. , 2007, Breast.

[37]  A. Luini,et al.  Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. , 1999, Journal of the National Cancer Institute.

[38]  A. Luini,et al.  The sentinel node biopsy after previous breast surgery: preliminary results on 543 patients treated at the European Institute of Oncology , 2004, Breast Cancer Research and Treatment.

[39]  D. Weaver,et al.  Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. , 1993, Surgical oncology.

[40]  J. Kuhn,et al.  Radiation safety with breast sentinel node biopsy. , 1999, American journal of surgery.

[41]  S. Strand,et al.  The "critical colloid dose" in studies of reticuloendothelial function. , 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[42]  T. Julian,et al.  Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  P. Veronesi,et al.  Sentinel Node Biopsy in Patients with Previous Breast Aesthetic Surgery , 2009, Annals of Surgical Oncology.

[44]  Mark C Kelley,et al.  Lymphatic mapping and sentinel lymphadenectomy for breast cancer. , 2004, American journal of surgery.

[45]  S. Leong,et al.  Principles and controversies in lymphoscintigraphy with emphasis on breast cancer. , 2000, The Surgical clinics of North America.

[46]  H. Cody,et al.  Intradermal Radiocolloid and Intraparenchymal Blue Dye Injection Optimize Sentinel Node Identification in Breast Cancer Patients , 1999, Annals of Surgical Oncology.

[47]  P. Heikkilä,et al.  The outcome of sentinel node biopsy in breast cancer patients with preoperative surgical biopsy , 2009, Journal of surgical oncology.

[48]  H. Kuerer,et al.  The Safety of Lymphatic Mapping in Pregnant Breast Cancer Patients Using Tc‐99m Sulfur Colloid , 2004, The breast journal.

[49]  D. Krag,et al.  The False-Negative Rate of Sentinel Node Biopsy in Patients with Breast Cancer: A Meta-Analysis , 2012, World Journal of Surgery.

[50]  A. Purushotham,et al.  Lymphatic mapping and sentinel node biopsy in breast cancer. , 1997, JAMA.

[51]  A. Luini,et al.  Axillary metastases in breast cancer patients with negative sentinel nodes: a follow-up of 3548 cases. , 2009, European journal of cancer.

[52]  Peter J. Ell,et al.  Dosimetry and Radiation Protection , 2021, Nuclear and Radiochemistry.

[53]  A. Giuliano,et al.  Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. , 2011, JAMA.

[54]  A. Giuliano,et al.  Sentinel Lymph Node Biopsy for Local Recurrence of Breast Cancer After Breast-Conserving Therapy , 2006, Annals of Surgical Oncology.

[55]  M. Wallack,et al.  Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable, or nonpalpable breast cancer. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[56]  A. Luini,et al.  Sentinel Lymph Node Biopsy in Multicentric Breast Cancer: Five-Year Results in a Large Series from a Single Institution , 2011, Annals of Surgical Oncology.

[57]  J. Machac,et al.  Effect of High Specific‐Activity Sulfur Colloid Preparations on Sentinel Node Count Rates , 2002, Clinical nuclear medicine.

[58]  N. Hansen,et al.  The benefits and limitations of sentinel lymph node biopsy , 2006, Current treatment options in oncology.

[59]  Philip Varghese,et al.  Methylene Blue Dye—A Safe and Effective Alternative for Sentinel Lymph Node Localization , 2008, The breast journal.

[60]  M. Noguchi,et al.  Diagnosis of axillary lymph node metastases in patients with breast cancer , 2005, Breast Cancer Research and Treatment.

[61]  C K Hoh,et al.  A synthetic macromolecule for sentinel node detection: (99m)Tc-DTPA-mannosyl-dextran. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[62]  K. McMasters,et al.  Practical guidelines for optimal gamma probe detection of sentinel lymph nodes in breast cancer: results of a multi-institutional study. For the University of Louisville Breast Cancer Study Group. , 2000, Surgery.

[63]  M. McCarter,et al.  Localization of the Sentinel Node in Breast Cancer: Identical Results With Same-Day and Day-Before Isotope Injection , 2001, Annals of Surgical Oncology.

[64]  R. Carlos,et al.  Breast cancer sentinel node identification and classification after neoadjuvant chemotherapy-systematic review and meta analysis. , 2009, Academic radiology.

[65]  U. Veronesi,et al.  Internal mammary node lymphoscintigraphy and biopsy in breast cancer. , 2002, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.

[66]  A. Y. de Kanter,et al.  Radiation protection for the sentinel node procedure in breast cancer. , 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[67]  A. V. van Dongen,et al.  Further optimisation of 99mTc-Nanocoll sentinel node localisation in carcinoma of the breast by improved labelling , 2001, European Journal of Nuclear Medicine.

[68]  W. Studer,et al.  Anaphylaxis to isosulfan blue and cross-reactivity to patent blue V: case report and review of the nomenclature of vital blue dyes. , 2006, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[69]  G. Schwartz,et al.  Accuracy of Axillary Sentinel Lymph Node Biopsy Following Neoadjuvant (Induction) Chemotherapy for Carcinoma of the Breast , 2003, The breast journal.

[70]  H. S. Osborne,et al.  The international electrotechnical commission , 1953, Electrical Engineering.

[71]  D. Agnese,et al.  Advances in the surgical management of early stage invasive breast cancer. , 2004, Current problems in surgery.

[72]  C. Quinn,et al.  The significance of immunohistochemistry positivity in sentinel nodes which are negative on haematoxylin and eosin in breast cancer. , 2009, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[73]  G. Escaramís,et al.  Predicting Non‐Sentinel Lymph Node Status in Breast Cancer Patients with Sentinel Lymph Node Involvement: Evaluation of Two Scoring Systems , 2010, The breast journal.

[74]  Keshtgar.  Sentinel Lymph Node Biopsy in Carcinoma of the Breast , 1999 .

[75]  O. Nieweg,et al.  Rationale for superficial injection techniques in lymphatic mapping in breast cancer patients , 2004, Journal of surgical oncology.

[76]  B. Persson,et al.  Dosimetry in lymphoscintigraphy of Tc-99m antimony sulfide colloid. , 1982, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[77]  C. Nos,et al.  New anatomical classification of the axilla with implications for sentinel node biopsy , 2010, The British journal of surgery.

[78]  A. Soran,et al.  Models for predicting non‐sentinel lymph node positivity in sentinel node positive breast cancer: the importance of scoring system , 2008, International journal of clinical practice.

[79]  J. Maublant,et al.  Sentinel node in breast cancer procedural guidelines , 2007 .

[80]  J. Thompson,et al.  Mammary lymphoscintigraphy in breast cancer. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[81]  S. Heller,et al.  The intraoperative gamma probe: basic principles and choices available. , 2000, Seminars in nuclear medicine.

[82]  G. Babiera,et al.  Prospective Multicentric Randomized Study Comparing Periareolar and Peritumoral Injection of Radiotracer and Blue Dye for the Detection of Sentinel Lymph Node in Breast Sparing Procedures: FRANSENODE Trial , 2008 .

[83]  W. Waddington,et al.  Radiation Protection in Radioguided Surgery , 2008 .

[84]  A. Taylor,et al.  Dynamic lymphoscintigraphy to identify the sentinel and satellite nodes. , 1996, Clinical nuclear medicine.

[85]  G. Capitanio,et al.  Sentinel node biopsy in breast cancer. , 2003, Breast.

[86]  Umberto Veronesi,et al.  Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study. , 2006, The Lancet. Oncology.

[87]  C. Collins,et al.  The sentinel node in breast cancer , 2008, Cancer imaging : the official publication of the International Cancer Imaging Society.

[88]  J. Aarsvold,et al.  Sentinel node staging of early breast cancer using lymphoscintigraphy and the intraoperative gamma-detecting probe. , 2000, Seminars in nuclear medicine.

[89]  Monica Morrow,et al.  Locoregional treatment of primary breast cancer , 2010, Cancer.

[90]  A. Lanzavecchia,et al.  The mannose receptor functions as a high capacity and broad specificity antigen receptor in human dendritic cells , 1997, European journal of immunology.

[91]  A. Luini,et al.  Radiation protection in radioguided surgery of breast cancer. , 1999, Nuclear medicine communications.

[92]  G. Ian Taylor,et al.  Annals of Surgical Oncology 15(3):863–871 DOI: 10.1245/s10434-007-9709-9 The Lymphatic Anatomy of the Breast and its Implications for Sentinel Lymph Node Biopsy: A Human Cadaver Study , 2022 .

[93]  I. V. D. van der Ploeg,et al.  Axillary recurrence after a tumour-negative sentinel node biopsy in breast cancer patients: A systematic review and meta-analysis of the literature. , 2008, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[94]  G. Bisi,et al.  Sentinel lymph node detection in patients with early-stage breast cancer: comparison of periareolar and subdermal/peritumoral injection techniques. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[95]  C. Lawton.  Association of Occult Metastases in Sentinel Lymph Nodes and Bone Marrow With Survival Among Women With Early-Stage Invasive Breast Cancer , 2012 .

[96]  A. Luini,et al.  Can sentinel node biopsy avoid axillary dissection in clinically node-negative breast cancer patients? , 1998 .

[97]  T. Toivonen,et al.  The Clinical Value of Parasternal Sentinel Node Biopsy in Breast Cancer , 2006, Annals of Surgical Oncology.

[98]  G. Schwartz,et al.  Proceeding of the consensus conference of the role of sentinel lymph node biopsy in carcinoma or the breast April 19-22, 2001, Philadelphia, PA, USA. , 2002, The breast journal.

[99]  J. Donohue,et al.  Axillary Recurrence in Breast Cancer Patients with Isolated Tumor Cells in the Sentinel Lymph Node [AJCC N0(i+)] , 2010, Annals of Surgical Oncology.

[100]  A. Giuliano,et al.  Proceedings of the Consensus Conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19–22, 2001, Philadelphia, Pennsylvania , 2002, Cancer.

[101]  J. S. Vicente,et al.  Optimization of sentinel lymph node biopsy in breast cancer by intraoperative axillary palpation , 2010 .

[102]  T. Meretoja,et al.  Multicentre validation of different predictive tools of non-sentinel lymph node involvement in breast cancer. , 2012, Surgical oncology.

[103]  G. Q. della Rovere,et al.  Management of the axilla in women with breast cancer. , 2007, The Lancet. Oncology.

[104]  E. Rutgers,et al.  Improved sentinel node visualization in breast cancer by optimizing the colloid particle concentration and tracer dosage , 2001, Nuclear medicine communications.

[105]  A. Kwong,et al.  Evaluation of patient effective dose from sentinel lymph node lymphoscintigraphy in breast cancer: a phantom study with SPECT/CT and ICRP-103 recommendations. , 2012, European journal of radiology.

[106]  Francesco Giammarile,et al.  Changing paradigms in radioguided surgery and intraoperative imaging: the GOSTT concept , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[107]  S H Muller,et al.  Evaluation of mammary lymphoscintigraphy by a single intratumoral injection for sentinel node identification. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[108]  S. Toyoshima,et al.  Double mapping with subareolar blue dye and peritumoral green dye injections decreases the false-negative rate of dye-only sentinel node biopsy for early breast cancer: 2-site injection is more accurate than 1-site injection. , 2006, Surgery.

[109]  Umberto Veronesi,et al.  Sentinel‐Node Biopsy to Avoid Axillary Dissection in Breast Cancer with Clinically Negative Lymph‐Nodes , 1998 .

[110]  John N Aarsvold,et al.  Update on detection of sentinel lymph nodes in patients with breast cancer. , 2005, Seminars in nuclear medicine.

[111]  M. Noguchi,et al.  Complement of peritumoral and subareolar injection in breast cancer sentinel lymph node biopsy , 2009, Journal of surgical oncology.

[112]  Ora Israel,et al.  SPECT/CT in tumor imaging: technical aspects and clinical applications. , 2003, Seminars in nuclear medicine.

[113]  H. Cody,et al.  Isosulfan blue dye reactions during sentinel lymph node mapping for breast cancer. , 2002, Anesthesia and analgesia.

[114]  A. Jemal,et al.  Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.

[115]  Kelly K. Hunt,et al.  Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. , 2010, Annals of surgery.

[116]  S. Singletary,et al.  Anaphylactic reactions to isosulfan blue dye during sentinel lymph node biopsy for breast cancer. , 2001, American journal of surgery.

[117]  A. Giuliano,et al.  Sentinel node biopsy in breast cancer. , 1999, Journal of the American College of Surgeons.

[118]  S. Duffy,et al.  Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[119]  G. Santamaría,et al.  Clinical relevance of sentinel lymph nodes in the internal mammary chain in breast cancer patients , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[120]  G. S. Mijnhout,et al.  Radiopharmaceuticals in sentinel lymph-node detection – an overview , 1999, European Journal of Nuclear Medicine.

[121]  L. Esserman,et al.  Is it necessary to harvest additional lymph nodes after resection of the most radioactive sentinel lymph node in breast cancer? , 2008, Journal of the American College of Surgeons.

[122]  M. Kissin,et al.  Quantitative assessment of the radiation hazards and risks in sentinel node procedures. , 2003, The British journal of radiology.

[123]  T. Toivonen,et al.  The sensitivity of axillary staging when using sentinel node biopsy in breast cancer. , 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[124]  Roland Holland,et al.  Image-detected breast cancer: state of the art diagnosis and treatment. , 2005, Journal of the American College of Surgeons.

[125]  A. Giuliano,et al.  Radiation Safety Considerations for Sentinel Node Techniques , 1999, Annals of Surgical Oncology.

[126]  E. Winer,et al.  American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[127]  S. Singletary,et al.  Incidence of anaphylactoid reactions to isosulfan blue dye during breast carcinoma lymphatic mapping in patients treated with preoperative prophylaxis , 2005, Cancer.

[128]  A E Giuliano,et al.  Sentinel lymphadenectomy in breast cancer. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[129]  T. Meretoja,et al.  Sentinel Node Biopsy in Breast Cancer Patients with Large or Multifocal Tumors , 2009, Annals of surgical oncology.

[130]  M. Ross,et al.  A prospective study comparing touch imprint cytology, frozen section analysis, and rapid cytokeratin immunostain for intraoperative evaluation of axillary sentinel lymph nodes in breast cancer , 2009, Cancer.

[131]  T. Julian,et al.  Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. , 2007, The Lancet. Oncology.

[132]  B. Hesse,et al.  Factors of importance for scintigraphic non-visualisation of sentinel nodes in breast cancer , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[133]  M. Bolla,et al.  Can the sentinel lymph node technique affect decisions to offer internal mammary chain irradiation? , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[134]  Seho Park,et al.  How Many Sentinel Lymph Nodes Are Enough for Accurate Axillary Staging in T1-2 Breast Cancer? , 2011, Journal of breast cancer.

[135]  H. Carmalt,et al.  SPECT/CT scans allow precise anatomical location of sentinel lymph nodes in breast cancer and redefine lymphatic drainage from the breast to the axilla. , 2012, Breast.

[136]  S. Singletary,et al.  Lymphatic Drainage Patterns on Early Versus Delayed Breast Lymphoscintigraphy Performed after Injection of Filtered Tc-99m Sulfur Colloid in Breast Cancer Patients Undergoing Sentinel Lymph Node Biopsy , 2005, Clinical Nuclear Medicine.

[137]  R. Mansel,et al.  Sentinel Node Biopsy in Breast Cancer: ALMANAC Trial , 2001, World Journal of Surgery.

[138]  J. Thompson,et al.  Sentinel lymph node detection and imaging. , 1999, European journal of nuclear medicine.

[139]  E. Vega,et al.  Particle sizes of colloids to be used in sentinel lymph node radiolocalization , 2008, Nuclear medicine communications.

[140]  P. Wu,et al.  Patient effective dose from sentinel lymph node lymphoscintigraphy in breast cancer: a study using a female humanoid phantom and thermoluminescent dosemeters. , 2003, The British journal of radiology.

[141]  A. Giuliano,et al.  Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast April 19 to 22, 2001, Philadelphia, Pennsylvania. , 2002, Human pathology.

[142]  H. Wagner,et al.  Studies of the reticuloendothelial system (RES). I. Measurement of the phagocytic capacity of the RES in man and dog. , 1963, The Journal of clinical investigation.

[143]  T. Stephenson,et al.  Radiation‐guided breast sentinel lymph node biopsies – is a handling delay for radiation protection necessary? , 2012, Histopathology.

[144]  P. V. van Diest,et al.  Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[145]  I. V. D. van der Ploeg,et al.  SPECT/CT for preoperative sentinel node localization , 2010, Journal of surgical oncology.

[146]  M. Brennan,et al.  Accuracy of sentinel lymph node biopsy in large and multifocal/multicentric breast carcinoma--a systematic review. , 2011, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[147]  D L Morton,et al.  Technical details of intraoperative lymphatic mapping for early stage melanoma. , 1992, Archives of surgery.

[148]  A. Kwong,et al.  Sentinel lymph node technique for breast cancer: radiation safety issues. , 2004, Seminars in oncology.

[149]  R. Newcombe,et al.  Clinical relevance of multiple sentinel nodes in patients with breast cancer , 2005, The British journal of surgery.

[150]  U. Metser,et al.  Lymphoscintigraphic sentinel node identification in patients with breast cancer: the role of SPECT-CT , 2006, European Journal of Nuclear Medicine and Molecular Imaging.

[151]  Umberto Veronesi,et al.  Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes , 1997, The Lancet.

[152]  W. Vogel,et al.  The yield of SPECT/CT for anatomical lymphatic mapping in patients with breast cancer , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[153]  M. Mihm,et al.  EANM-EORTC general recommendations for sentinel node diagnostics in melanoma , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[154]  X. Matías-Guiu,et al.  Diagnosis of the sentinel lymph node in breast cancer: a reproducible molecular method: a multicentric Spanish study , 2011, Histopathology.

[155]  L. Dauer,et al.  Organ and fetal absorbed dose estimates from 99mTc-sulfur colloid lymphoscintigraphy and sentinel node localization in breast cancer patients. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[156]  J. Machac,et al.  Factors affecting visualization rates of internal mammary sentinel nodes during lymphoscintigraphy. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[157]  S. Lakhani,et al.  Radiation safety of the sentinel lymph node technique in breast cancer , 2000, European Journal of Nuclear Medicine.

[158]  P. Spanheimer,et al.  Measurement of Uterine Radiation Exposure from Lymphoscintigraphy Indicates Safety of Sentinel Lymph Node Biopsy during Pregnancy , 2009, Annals of Surgical Oncology.

[159]  B. Hesse,et al.  Radiation doses to staff involved in sentinel node operations for breast cancer , 2005, Clinical physiology and functional imaging.

[160]  G Villa,et al.  Radioguided Sentinel Lymph Node Biopsy in Breast Cancer Surgery* , 2002 .

[161]  A. Luini,et al.  Safety of sentinel node biopsy in pregnant patients with breast cancer. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[162]  L. Mariani,et al.  The dissection of internal mammary nodes does not improve the survival of breast cancer patients. 30-year results of a randomised trial. , 1999, European journal of cancer.